HOME >> BIOLOGY >> NEWS
Chemical Heritage Foundation and BIO give Biotechnology Heritage Award to William Rutter

PHILADELPHIA June 24, 2003 -- The Chemical Heritage Foundation (CHF) and the Biotechnology Industry Organization (BIO) presented the 2003 Biotechnology Heritage Award to William J. Rutter at a Plenary Lunch Session of BIO Conference in Washington DC on Tuesday, June 24. A biotechnology pioneer, Rutter cofounded Chiron Corporation and directed the Hormone Research Institute at the University of California, San Francisco (UCSF), for nearly a decade.

"Leader of a top research institute, cofounder of a pioneering biotechnology company, Bill Rutter is that rare combination of entrepreneurial spirit and high-level management skills so important to the rapid growth of biotechnology both as a discipline and as a global industry," said Arnold Thackray, president of CHF.

The Biotechnology Heritage Award recognizes individuals who have made significant contributions to the development of biotechnology through discovery, innovation, and public understanding. Walter Gilbert and Phillip A. Sharp were honored in 2002 for founding Biogen, a pioneer company in biotechnology. Both men are Nobel laureates. Francis S. Collins, director of the National Human Genome Research Institute, and J. Craig Venter, former president of Celera Genomics, received the award in 2001 for their key roles in the sequencing of the human genome.

About William J. Rutter

Rutter is the cofounder of Chiron Corporation and served as chairman of its Board of Directors from Chiron's inception in 1981 until 1999. In 1969 Rutter joined the faculty of UCSF as Hertzstein Professor and served as the chairman of the Department of Biochemistry and Biophysics from 1969 to 1982. As department chair, he spearheaded the drive to turn the department and the School of Medicine into leading research organizations, with emphasis on an interdisciplinary molecular approach.

From August 1983 through April 1989, in addition to his responsibilities at Chiron, Rutter was the direct
'"/>

Contact: Neil Gussman
ngussman@dejazzd.com
717-314-2494
Chemical Heritage Foundation
25-Jun-2003


Page: 1 2

Related biology news :

1. Chemical engineering grad students will take notable national awards
2. Chemical derived from vitamin-E shows early promise as cancer drug
3. Chemical genetics identifies SARS inhibitors
4. Chemical signals health of brain cells Symposium
5. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
6. Chemical engineers discover filtration system to help biotech industry
7. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
8. American Chemical Society media registration
9. Chemical Society announces EPA awards for environmentally friendly technology
10. NIH launches first center in Nationwide Chemical Genomics Network
11. Chemical reaction in birds provides sense of direction during migratory flights

Post Your Comments:
(Date:5/22/2013)... approach to genetic engineering drastically reduces the time ... bacteria, the workhorses of biotechnology, scientists are reporting. ... , the method paves the way for more ... environmental cleanup and other activities. , Keith Shearwin ... piece of the genetic material DNA into a ...
(Date:5/22/2013)... details on how climate change will affect interactions between ... Journal of Animal Ecology . This knowledge, they ... policymakers of how species are likely to be impacted ... growing recognition among biologists that climate change is affecting ... is going to have very important consequences for the ...
(Date:5/21/2013)... long time that some creatures evolve more quickly than ... But it may be that height plays a role, ... U. S. National Evolutionary Synthesis Center. , In ... journal Nature Communications , Lanfear and colleagues report ... a database of global patterns in plant height for ...
Breaking Biology News(10 mins):UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5Small but speedy: Short plants live in the evolutionary fast lane 2
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
(Date:5/23/2013)... May 23, 2013 PuraMed BioScience ® ... marketer of over-the-counter (OTC) medicinal and healthcare products, ... on the company based on low market capitalization ... Non-Prescription, All Natural Product to Treat Migraine Headaches ... #1 Prescription Competitor , Currently Available Nationwide ...
(Date:5/23/2013)... Calif. , May 23, 2013  Saddleback Memorial ... recently became the first hospital on the West ... technology. This new surgical option provides women with a ... Marc Winter , M.D., a ... and surgeon and medical director of minimally invasive surgery ...
(Date:5/23/2013)... , May 23, 2013 Northwest Biotherapeutics ... company developing DCVax ® personalized immune therapies for ... its exhibit at this year,s American Society Of Clinical ... to highlight its leadership role in immune therapy.  ... ASCO annual meeting is the pre-eminent conference focused on ...
Breaking Biology Technology:Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3
Cached News: